Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm

一项随机I期研究，比较序贯（“启动”）与同步地西他滨联合克拉屈滨、阿糖胞苷、粒细胞集落刺激因子和米托蒽醌（CLAG-M）治疗新诊断或复发/难治性急性髓系白血病（AML）或其他高级别髓系肿瘤成人患者的疗效。